Testing effectiveness (Phase 2)Study completedNCT03377361
What this trial is testing
An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread
Who this might be right for
Colorectal CancerColorectal TumorsColorectal Carcinoma+1 more
Bristol-Myers Squibb 325